Ligamentum Teres Cardiopexy Might Not Prevent Gastro-esophageal Reflux After Laparoscopic Sleeve Gastrectomy: Case Series

Obes Surg. 2023 Mar;33(3):965-968. doi: 10.1007/s11695-022-06413-1. Epub 2022 Dec 31.

Abstract

Roux-en-Y gastric bypass (RYGB) is considered the gold standard procedure in patients with obesity and gastroesophageal reflux (GERD), but in patients with preoperative hiatal hernia (HH) or GERD, who are unfit for RYGB, there are no clear guidelines. Ligamentum teres cardiopexy (LTC) has been proposed as an effective alternative. The purpose of this study was to analyze medium-term results of LTC procedure associated with laparoscopic sleeve gastrectomy (LSG) in patients with GERD or HH, according to the absence of pathologic acid reflux in esophageal 24 h pH monitoring test, symptom release, or PPI reduction. Five patients underwent LSG-LTC between March 2018 and October 2019. In one patient, the effectiveness of LTC as an anti-reflux procedure could not be assessed because of conversion to RYGB was required. After a follow-up period of 30 [24-42] months and excessive BMI loss of 62.74 ± 18.18%, GERD recurrence was observed in 75% of patients. The study was discontinued due to unsatisfactory preliminary results with LTC. Our results suggest that LTC might not prevent GERD after LSG in patients with preoperative GERD or HH.

Keywords: Gastric precancerous lesions; Gastro-esophageal reflux; Hiatal hernia; Ligamentum teres cardiopexy; Sleeve gastrectomy.

MeSH terms

  • Gastrectomy / methods
  • Gastric Bypass* / methods
  • Gastroesophageal Reflux* / complications
  • Gastroesophageal Reflux* / prevention & control
  • Gastroesophageal Reflux* / surgery
  • Hernia, Hiatal* / complications
  • Humans
  • Laparoscopy* / adverse effects
  • Obesity, Morbid* / surgery
  • Retrospective Studies
  • Round Ligaments* / surgery
  • Treatment Outcome